In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: Implications for treatment of HIV infection and other immune disorders

Clinical Immunology

Volumn 109, Issue 3, 2003, Pages 355-358

  Biswas, Priscilla ^a   Mantelli, Barbara ^a   Hasson, Hamid ^a   Vecchi, Andrea ^a   Saniabadi, Abby ^b   Lazzarin, Adriano ^a   Beretta, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Japan Immunoresearch Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR CXCR3;

ARTICLE; BONE MARROW CELL; CHRONIC DISEASE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY CELL; LEUKOCYTE; MONOCYTE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0141718456     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.07.001     Document Type: Article

References (23)

1. Moser B., Loetcher P. Lymphocte traffic control by chemokines. Nature Immunol. 2:2001;123-128.
2. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. Chemokine receptor specific for IP-10 and Mig structure, function and expression in activated T lymphocytes . J. Exp. Med. 184:1996;963-969.
3. Salomon I., Netzer N., Wildbaum G., Schif-Zuck S., Maor G., Karin N. Targeting the function of IFN-gamma-inducible Protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169:2002;2685-2693.
4. Shadidi K.R., Thompson K.M., Henriksen J.E., Natvig J.B., Aarvak T. Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis. Scand. J. Immunol. 274:2002;274-283.
5. Yuan Y.H., ten Hove T., The F.O., Slors J.F., van Deventer S.J., te Velde A.A. Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm. Bowel. Dis. 7:2001;281-286.
6. Rottman J.B., Tammy L.S., Ganley K.G., Kikuchi T., Krueger J.G. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin aEb7 in the pathogenesis of Psoriasis Vulgaris. Lab. Invest. 81:2001;335-347.
7. Mahad D.J., Howell S.J., Woodroofe M.N. Expression of chemokines in the CSF and correlation with disease activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 72:2002;498-502.
8. Misu T., Onodera H., Fujihara K., Matsushima K., Yoshie O., Okita N., Takase S., Itoyama Y. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis imbalance of Th1/Th2-associated chemokine signalling . J. Neuroimmunol. 114:2001;207-212.
9. Aust G., Sittig D., Steiner M., Lamesch P., Lohmann T. Grave's disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripher blood lymphocytes. Clin. Exp. Immunol. 127:2002;479-485.
10. Hancock W.W., Lu B., Gao W., Csizmadia V., Faia K., King J.A., Smiley S.T., Ling M., Gerard N.P., Gerard C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 20:2000;1515-1520.
11. Hancock W.W., Gao W., Csizmadia V., Faia K.L., Shemmeri N., Luster A.D. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193:2001;975-980.
12. Shields P.L., Morland C.M., Salmon M., Quin S., Hubscher S.G., Adams S.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 163:1999;6236-6243.
13. Belperio J.A., Keane M.P., Burdick M.D., Lynch J.P., Xue Y.Y., Li K., Ross D.J., Strieter R.M. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 169:2002;1037-1049.
14. Haase A.T. Population biology of HIV-1 infection viral and CD4+ T cell demographics and dynamics in lymphatic tissues . Annu. Rev. Immunol. 17:1999;625-656.
15. T.A. Reinhart, B.A. Fallert, M.E. Pfeifer, S. Sangavi, S. Capuano III, P. Rajakumar, M. Murphey-Corb, R. Day, C.L. Fuller, T.M. Schaefer, Blood 99 (2002) 3119-3128.
16. Kashiwagi N., Saniabadi A., Shimoyama T. Immunomodulatory effects of granulocyt and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig. Dis. Sci. 47:2002;1334-1341.
17. Fujimori J., Yoshino S., Koiwa M., Hirai H., Hayama N., Iino Y. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1. Rheumatol. Int. 15:1996;175-180.
18. Kashiwagi N., Hirata I., Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Therapeutic Apheresis. 2:1998;134-141.
19. Lazzarin A., Hasson H., Saniabadi A., Clerici M., Beretta A. Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis. J. Clin. Apher. 16:2001;33-34.
20. Hasson H., Saniabadi A., Alfano M., Trabattoni D., Ferrante P., Lillo F., Clerici M., Lazzarin A., Beretta A. Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART. J. Biol. Reg. Homeost. Ag. 16:2002;58-64.
21. Beretta A., Hasson H., Saniabadi A., Alfano M., Trabattoni D., Lillo F., Ferrante P., Clerici M., Lazzarin A. Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients short-term and long-term effects on immunological and virological parameters . Perfusion. 17:2002;47-51.
22. Cassatella M.A., Gasperini S., Calzetti A., Bertagnin A., Luster A.D., McDonald P.P. Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27:1997;111-115.
23. Gasperini S., Marchi M., Calzetti F., Laudanna C., Vicentini L., Olsen H., Murphy M., Liao F., Farber J.A., Cassatella M.A. (1999) Gene expression and production of monokine induced by IFN-gamma (MIG), IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162:1999;4928-4937.